Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof

A method for treating an ophthalmological disease, condition or pathology in a mammalian subject in need of such treatment comprising delivering to the subject by intraocular injection, an effective amount of a composition comprising:

• (a) a therapeutically effective quantity of triamcinolone or a derivative thereof;
• (b) a therapeutically effective quantity of moxifloxacin;
• (c) a non-ionic poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) block copolymer having a molecular weight of the polyoxypropylene portion of about 4,000 Daltons and about a 70% polyoxyethylene content, with an overall molecular weight of between about 9,840 Daltons and about 14,600 Daltons, wherein the concentration of the non-ionic polyoxyethlene-polyoxypropylene block copolymer is between about 1 mass % and about 2 mass % of the pharmaceutical composition;
• (d) about 1% of polysorbate 80;
• and
• (e) a pharmaceutically acceptable carrier.